Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
18 pending office actions • 11 art units • 17 examiners • 0 of 18 (0%) have an AI response strategy ready • 17 patents granted in the last 365 days
Biogen Ma Inc. manages a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The company currently has 17 pending office actions. These matters are spread across 11 distinct art units, reflecting the nature of pharmaceutical and biotechnological innovation. This distribution across 11 art units suggests that the company's research spans multiple specialized biological and chemical disciplines within the USPTO examination framework.
Prosecution is handled by 16 distinct examiners. Alexandra Elizabeth Lalonde is the busiest examiner for the portfolio, with 2 pending office actions. The fact that 16 examiners are managing 17 actions shows that nearly every pending matter is being reviewed by a different individual, with only minimal overlap in examiner assignment. For a practitioner, this indicates that prosecution strategies are tailored to 16 distinct examiners and 11 art units rather than a single concentrated group.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (6%) |
| §103 only | 2 (11%) |
| §102 only | 1 (6%) |
| §112 only | 2 (11%) |
| Double-patenting + other | 3 (17%) |
| Multi-statute (no §101) | 9 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LALONDE, ALEXANDRA ELIZABETH | 2 | 71.1% | +33.0% |
| SHIN, DANA H | 1 | 27.0% | +27.0% |
| NEAGU, IRINA | 1 | 46.8% | +57.3% |
| WHITE, DAWANNA SHAR-DAY | 1 | 62.5% | +23.3% |
| MEDWAY, SCOTT J | 1 | 66.7% | +23.4% |
| BARRON, SEAN C | 1 | 52.9% | +30.9% |
| JARRELL, NOBLE E | 1 | 81.1% | +9.7% |
| VU, JAKE MINH | 1 | 41.1% | +27.2% |
| SANCHEZ, JUSTIN CHRISTOPHER | 1 | 88.7% | +10.2% |
| CHERNYSHEV, OLGA N | 1 | 54.5% | +34.4% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18692541 | DIROXIMEL FUMARATE PARTICLES HAVING IMPROVED FLOW PROPERTIES AND METHODS OF MAKING SAME | JARRELL, NOBLE E | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17380694 | MONITORING BASED ON CONTINUOUS INTRACRANIAL EEG ACTIVITY | SHOSTAK, ANDREY | 118d overdue |
| 19172111 | METHODS OF TREATING OR PREVENTING SPINAL MUSCULAR ATROPHY | SHIN, DANA H | — |
| 18765894 | MEDICAL DEVICE HAVING NON-FILTERED CSF WITHDRAWAL PATHWAY | MEDWAY, SCOTT J | — |
| 18571090 | SYNTHETIC PREPARATION FOR DIROXIMEL FUMARATE | SANCHEZ, JUSTIN CHRISTOPHER | — |
| 18567674 | METHODS FOR TREATING ALZHEIMER'S DISEASE | CHERNYSHEV, OLGA N | — |
| 18286721 | COMPOSITIONS AND METHODS FOR TREATING CHRONIC ACTIVE WHITE MATTER LESIONS / RADIOLOGICALLY ISOLATED SYNDROME | AEDER, SEAN E | — |
| 18283925 | NUCLEIC ACID DELIVERY TO THE CENTRAL NERVOUS SYSTEM | LEITH, NANCY J | — |
| 18273053 | MICROTUBULE DESTABILIZER ADDITIVES TO INCREASE RECOMBINANT VIRAL VECTOR TITERS | GRIZER, CASSANDRA SENN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19172111 | METHODS OF TREATING OR PREVENTING SPINAL MUSCULAR ATROPHY | SHIN, DANA H | — |
| 18864351 | CRYSTALLINE POLYMORPHS OF N-METHYL-N-((1S,3S)-3-METHYL-3-((6-(1-METHYL-1H-PYRAZOL-4-YL)PYRAZOLO[1,5-A]PYRAZIN-4-YL)OXY)CYCLOBUTYL)ACRYLAMIDE | NEAGU, IRINA | — |
| 18837245 | EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF | WHITE, DAWANNA SHAR-DAY | — |
| 18765894 | MEDICAL DEVICE HAVING NON-FILTERED CSF WITHDRAWAL PATHWAY | MEDWAY, SCOTT J | — |
| 18717244 | METHODS AND SYSTEMS FOR TRANSFECTING HOST CELLS | BARRON, SEAN C | — |
| 18397190 | METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES | VU, JAKE MINH | — |
| 18571090 | SYNTHETIC PREPARATION FOR DIROXIMEL FUMARATE | SANCHEZ, JUSTIN CHRISTOPHER | — |
| 18567674 | METHODS FOR TREATING ALZHEIMER'S DISEASE | CHERNYSHEV, OLGA N | — |
| Art Unit | Apps |
|---|---|
| 3783 | 2 |
| 1635 | 1 |
| 1699 | 1 |
| 1622 | 1 |
| 1642 | 1 |
| 1636 | 1 |
| 1672 | 1 |
| 1674 | 1 |
| 1641 | 1 |
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19172111 | METHODS OF TREATING OR PREVENTING SPINAL MUSCULAR ATROPHY | SHIN, DANA H | 1635 | §103DP | Non-Final OA | — | Pending | Apr 07, 2025 |
| 18864351 | CRYSTALLINE POLYMORPHS OF N-METHYL-N-((1S,3S)-3-METHYL-3-((6-(1-METHYL-1H-PYRAZOL-4-YL)PYRAZOLO[1,5-A]PYRAZIN-4-YL)OXY)CYCLOBUTYL)ACRYLAMIDE | NEAGU, IRINA | — | §102§112DP | Non-Final OA | — | Pending | Nov 08, 2024 |
| 18837245 | EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF | WHITE, DAWANNA SHAR-DAY | — | §112 | Non-Final OA | — | Pending | Aug 09, 2024 |
| 18765894 | MEDICAL DEVICE HAVING NON-FILTERED CSF WITHDRAWAL PATHWAY | MEDWAY, SCOTT J | — | §102§103Other | Non-Final OA | — | Pending | Jul 08, 2024 |
| 18717244 | METHODS AND SYSTEMS FOR TRANSFECTING HOST CELLS | BARRON, SEAN C | — | §103 | Non-Final OA | — | Pending | Jun 06, 2024 |
| 18692541 | DIROXIMEL FUMARATE PARTICLES HAVING IMPROVED FLOW PROPERTIES AND METHODS OF MAKING SAME | JARRELL, NOBLE E | 1699 | §102 | Non-Final OA | — | Pending | Mar 15, 2024 |
| 18397190 | METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES | VU, JAKE MINH | — | §112Other | Non-Final OA | — | Pending | Dec 27, 2023 |
| 18571090 | SYNTHETIC PREPARATION FOR DIROXIMEL FUMARATE | SANCHEZ, JUSTIN CHRISTOPHER | 1622 | §103§112 | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18567674 | METHODS FOR TREATING ALZHEIMER'S DISEASE | CHERNYSHEV, OLGA N | — | §101§103§112 | Non-Final OA | — | Pending | Dec 06, 2023 |
| 18286721 | COMPOSITIONS AND METHODS FOR TREATING CHRONIC ACTIVE WHITE MATTER LESIONS / RADIOLOGICALLY ISOLATED SYNDROME | AEDER, SEAN E | 1642 | §102§103§112 | Non-Final OA | — | Pending | Oct 12, 2023 |
| 18283925 | NUCLEIC ACID DELIVERY TO THE CENTRAL NERVOUS SYSTEM | LEITH, NANCY J | 1636 | §102§103§112 | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18273053 | MICROTUBULE DESTABILIZER ADDITIVES TO INCREASE RECOMBINANT VIRAL VECTOR TITERS | GRIZER, CASSANDRA SENN | 1672 | §103§112 | Non-Final OA | — | Pending | Jul 19, 2023 |
| 18196506 | IMPLANTABLE MEDICAL DEVICE AND SYSTEM | LALONDE, ALEXANDRA ELIZABETH | 3783 | §103§112 | Non-Final OA | — | Pending | May 12, 2023 |
| 18036620 | BIPHASIC SUBCUTANEOUS DOSING REGIMENS FOR ANTI-VLA-4 ANTIBODIES | MIDDLETON, DANAYA L | 1674 | §102§103§112DP | Final Rejection | 79d overdue | Pending | May 11, 2023 |
| 18300339 | PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-BETA AMYLOID ANTIBODIES | KIM, YUNSOO | 1641 | §103§112 | Non-Final OA | — | Pending | Apr 13, 2023 |
| 18021643 | METHODS FOR TREATING REMITTING MULTIPLE SCLEROSIS | CORNET, JEAN P | 1628 | §103Other | Non-Final OA | 49d overdue | Pending | Feb 16, 2023 |
| 18070029 | IMPLANTABLE INTRAVENTRICULAR SAMPLING AND INFUSION ACCESS DEVICE | LALONDE, ALEXANDRA ELIZABETH | 3783 | §103§112 | Non-Final OA | — | Pending | Nov 28, 2022 |
| 17380694 | MONITORING BASED ON CONTINUOUS INTRACRANIAL EEG ACTIVITY | SHOSTAK, ANDREY | 3791 | §103§112 | Non-Final OA | 118d overdue | Pending | Jul 20, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial